A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD

• Status: Completed
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dey
• Treatments: Formoterol Fumarate

Criteria

Inclusion Criteria:

• Medical diagnosis of COPD

• Current or prior history of cigarette smoking

Exclusion Criteria:

• Medical diagnosis of asthma

• Chest X-ray diagnostic of significant disease other than COPD

• Significant condition or disease other than COPD